Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9379 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9205 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.9116 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.9067 |
High Similarity |
NPD4380 |
Phase 2 |
0.9028 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9028 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9013 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8966 |
High Similarity |
NPD1549 |
Phase 2 |
0.8889 |
High Similarity |
NPD1510 |
Phase 2 |
0.8882 |
High Similarity |
NPD7411 |
Suspended |
0.8828 |
High Similarity |
NPD2796 |
Approved |
0.8766 |
High Similarity |
NPD7819 |
Suspended |
0.8718 |
High Similarity |
NPD7075 |
Discontinued |
0.8718 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8701 |
High Similarity |
NPD1934 |
Approved |
0.8671 |
High Similarity |
NPD6959 |
Discontinued |
0.8645 |
High Similarity |
NPD2801 |
Approved |
0.8645 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8625 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8611 |
High Similarity |
NPD1240 |
Approved |
0.8608 |
High Similarity |
NPD5494 |
Approved |
0.858 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8543 |
High Similarity |
NPD1511 |
Approved |
0.8535 |
High Similarity |
NPD7768 |
Phase 2 |
0.8523 |
High Similarity |
NPD2800 |
Approved |
0.8493 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8481 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8467 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8462 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8431 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8395 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8395 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8395 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8345 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8302 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8301 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8278 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8263 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.8258 |
Intermediate Similarity |
NPD920 |
Approved |
0.8255 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8247 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8247 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8247 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8242 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8239 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8232 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8217 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8207 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8193 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8193 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8187 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.816 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8144 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8133 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8129 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8103 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.8103 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.8095 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8095 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8079 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8079 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8079 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8079 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8047 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8039 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8036 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.8026 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8025 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8024 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.8024 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8012 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7972 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7933 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7933 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7925 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7908 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7895 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7834 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7823 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7821 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7756 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7755 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7753 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7753 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7725 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7725 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7724 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7684 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7651 |
Intermediate Similarity |
NPD919 |
Approved |
0.7635 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7632 |
Intermediate Similarity |
NPD943 |
Approved |
0.7619 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.76 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7593 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7593 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7586 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7574 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7564 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7544 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7527 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7517 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7517 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7515 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4749 |
Approved |
0.75 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7472 |
Intermediate Similarity |
NPD4287 |
Approved |
0.747 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7455 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.745 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7432 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7432 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7427 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7421 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7417 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7403 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7394 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7394 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7386 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7368 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.736 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.736 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7358 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7356 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7355 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7349 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7315 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7305 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7278 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7278 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7278 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7278 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7262 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7256 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7248 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7246 |
Intermediate Similarity |
NPD37 |
Approved |
0.7244 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7244 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7244 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7241 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7239 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7234 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7233 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7233 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7233 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.723 |
Intermediate Similarity |
NPD17 |
Approved |
0.7219 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7219
|
Intermediate Similarity |
NPD4967 |
Phase 2 |